Detailed Information
Cited 8 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Measurable residual disease response in acute myeloid leukemia treated with venetoclax and azacitidine.
- Authors
- Pratz, K[Pratz, Keith]; Jonas, BA[Jonas, Brian Andrew]; Pullarkat, V[Pullarkat, Vinod]; Recher, C[Recher, Christian]; Schuh, AC[Schuh, Andre C.]; Thirman, MJ[Thirman, Michael J.]; Garcia, JS[Garcia, Jacqueline Suen]; Dinardo, CD[Dinardo, Courtney Denton]; Vorobyev, V[Vorobyev, Vladimir]; Fracchiolla, N[Fracchiolla, Nicola]; Yeh, SP[Yeh, Su-Peng]; Jang, JH[Jang, Jun Ho]; Ozcan, M[Ozcan, Muhit]; Yamamoto, K[Yamamoto, Kazuhito]; Illes, A[Illes, Arpad]; Zhou, Y[Zhou, Ying]; Dail, M[Dail, Monique]; Chyla, B[Chyla, Brenda]; Potluri, J[Potluri, Jalaja]; Dohner, H[Dohner, Hartmut]
- Issue Date
- 20-May-2021
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Citation
- JOURNAL OF CLINICAL ONCOLOGY, v.39, no.15
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF CLINICAL ONCOLOGY
- Volume
- 39
- Number
- 15
- ISSN
- 0732-183X
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - Medicine > Department of Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.